Connect with us

Politics

Denver Psilocybin Decriminalization Activist Pushes Back Against Michael Pollan’s Criticism

Published

on

Denver made history on Tuesday after voters approved a ballot measure to decriminalize psilocybin mushrooms. But shortly after the final count was released, reform advocates were hit with a New York Times op-ed signed by an unexpected critic telling them to slow their roll.

Despite being written by Michael Pollan, who authored a popular book debunking myths about psychedelics and defending their therapeutic potential, the opinion piece triggered pushback over its suggestion that “ballot initiatives may not be the smartest way” to change psilocybin laws and that advocates should wait for federal approval before legalizing the substance for medical purposes.

“Debate is always a good thing, but I worry that we’re not quite ready for this one,” Pollan wrote of campaigns in California and Oregon that are seeking to get psilocybin reform on the states’ 2020 ballots.

Kevin Matthews, campaign director of Decriminalize Denver, the group behind the city’s successful decriminalization initiative, told Marijuana Moment that he generally respected Pollan and appreciated the cautionary tale his piece offered against flippant consumption of the powerful substance—but he disagreed with the author’s stance on the ballot initiative process and with feedback from the research community opposing voter-led reform.

“Ballot initiatives are a good way to do this because I think sometimes the researchers forget about the average person out there who is currently using,” Matthews said. “There is this underground that exists—and Michael Pollan utilized that underground that exists [for his book].”

“If there’s enough support for the ballot initiative process to make sense, then I think people should go for it.”

Pollan’s argument boils down to this: he personally supports decriminalization—after all, as he noted, he’s illegally used and propagated psilocybin—but he argued that more research is needed on the substance’s “immense power and potential risk” and “consequences of unrestricted use” before activists start broadly changing laws concerning the substance.

It’s a line of messaging that drug policy reform advocates have heard time and again with respect to cannabis from lawmakers who reject legalization because they feel existing research is insufficient.

“We still have a lot to learn about the immense power and potential risk of these molecules, not to mention the consequences of unrestricted use,” Pollan wrote. “It would be a shame if the public is pushed to make premature decisions about psychedelics before the researchers have completed their work.”

The thing about that argument is that researchers have already uncovered evidence that psilocybin can be useful in the treatment of various mental health conditions such as post-traumatic stress disorder, addiction and depression.

Pollan understands those scientific findings well, but his op-ed shifts from lifting up the medical potential of the ingredient to urging caution against acting on those findings through ballot initiatives until researchers are satisfied.

“The more research we need should not impact whether or not we decriminalize it,” Matthews countered. “The more research we need is exploring its anti-addictive potential. One thing I hear is, ‘What are the long term impacts of use?’ We probably need more research there. But there’s no reason for people to go to jail for this if they’re not causing harm to others or themselves.”

The reality is that people across the U.S. are currently being criminalized for use and personal production of psilocybin mushrooms—a situation that can only be alleviated by voter-led ballot measures as long as lawmakers refuse to touch the issue.

After his piece generated considerable pushback on Twitter, Pollan clarified in a tweet that “this piece supports decriminalization, just not legalization now.” That message seemed to have been lost in translation, though, which is understandable given the author’s reference to campaigns that are simply seeking to decriminalize psilocybin before advocating against ballot initiatives.

If Pollan’s op-ed were published prior to the Denver vote, it is easy to imagine a situation where some number of the 1,979 voters who comprised the narrow margin between ‘yes’ and ‘no’ changed their minds because they read an essay from one of the nation’s foremost psychedelic advocates telling them that ballot measures “may not be the smartest way” to advance the issue.

That aside, more careful consideration of broader legalization is an area where Pollan and Matthews agree. After all, voter confusion about whether the Denver measure would allow people to purchase so-called “magic mushrooms” in shops—it does not—likely led some to vote against Initiative 301.

“I think the focus needs to be decriminalization. We should not be talking about necessarily a regulated medical model right now,” Matthews said. “I think decriminalization is the right first step because we need to make sure that people’s individual rights are protected, and really the only way to do that is by decriminalizing and making sure people are not receiving any kind of fines for possession.”

But while Pollan is urging caution, insisting that voters should wait for something akin to Food and Drug Administration approval before moving ahead on broad psilocybin reform, Matthews is striving to ensure that the Denver measure is quickly and effectively implemented, and to further spread awareness about the benefits of psilocybin through educational outreach.

When the first round of votes came out on Tuesday at 7:00 PM MT, showing the initiative behind by about 10 points, the “air got sucked out of the room like a space capsule getting a hole punched in it” at the main campaign watch party, Matthews said. But throughout the night, the gap narrowed. Victory became within reach.

When the final unofficially tally was finalized at approximately 4:20 PM MT the next day, Matthews said he “just started screaming and crying at the same time. Dogs started barking in the background.”

“What a trip,” he said, “no pun intended.”

But as the high of the success waned, Matthews recognized the momentous responsibility ahead of him, as one of the leaders of a historic campaign that will be looked at as activists attempt similar feats across the country. In spite of Pollan’s advice, Matthews has no intention of slowing down now.

California Activists Take First Steps To Decriminalize Psilocybin Mushrooms Statewide

Photo courtesy of Wikimedia/Workman.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Politics

Marijuana Banking Bill Will Get A Full House Floor Vote This Month

Published

on

A bipartisan bill to protect banks that service marijuana businesses will get a House floor vote by the end of the month, the office of Majority Leader Steny Hoyer (D-MD) confirmed to Marijuana Moment on Friday.

House leadership announced the decision to Democratic lawmakers at a closed-door meeting on Thursday.

“Mr. Hoyer said at the Whip meeting yesterday that he intends to move it this month,” a Hoyer staffer said in an email. “We’re discussing it with Members, but it hasn’t been scheduled just yet.”

Prior to confirmation from Hoyer’s office, four sources initially described the development to Marijuana Moment, with some saying the vote would be made under suspension of the rules—a procedure that is generally reserved for non-controversial legislation.

Voting on suspension would require two-thirds of the chamber (290 members) to vote in favor of the Secure and Fair Enforcement (SAFE) Banking Act in order for it to pass. The bill, which cleared the House Financial Services Committee in March, currently has 206 cosponsors, including 26 Republicans.

No amendments would be allowed to be added on the floor under the suspension process.

Problems could arise if lawmakers aren’t able to rally additional votes from conservative members or if there’s pushback over the strategy from progressive lawmakers, though it is unlikely Democratic leadership would advance the bill if they didn’t believe they have the votes for passage.

While interest in resolving the banking issue is generally bipartisan, it’s within reason to assume that lawmakers on both sides of the aisle might have wanted the opportunity to offer provisions such as extending protections to hemp businesses or adding language promoting social equity policies. That said, it is possible that leadership could file an entirely new piece of legislation that is similar to the SAFE Banking Act but contains modified provisions negotiated with key members and use that as the vehicle for floor action.

Many expected cannabis banking legislation to receive a floor vote before the August recess, but that did not come to fruition.

In any case, the development comes as the Senate Banking Committee is also preparing to hold a vote on marijuana banking legislation, with Chairman Mike Crapo (R-ID) announcing on Thursday that his panel is “working to try to get a bill ready.” He didn’t offer a timeline, however, other than saying he hoped to advance the legislation by the end of the year.

While sources told Marijuana Moment that Hoyer made his decision to allow cannabis banking vote following an earlier Wednesday meeting on the issue, it is likely that building momentum in the GOP-controlled Senate added to pressure on the House to act so that Democrats wouldn’t be seen as lagging behind Republicans on cannabis reform, an issue the party has sought to take political ownership of.

Following Crapo’s statement on advancing the banking legislation, Rep. Ed Perlmutter (D-CO), chief sponsor of the SAFE Banking Act, told Marijuana Moment that he welcomes the senator’s “commitment to resolve the banking conflicts that have been created by the misalignment in state and federal law on the issue of cannabis.”

“I remain focused on passing the SAFE Banking Act out of the House and look forward to working with my colleagues in the Senate as they take up the SAFE Banking Act or work to develop and pass similar legislation,” he said.

Banking access is largely seen as one of the most achievable pieces of cannabis legislation that stands to pass this Congress. Advocates and reform-minded lawmakers view it as one of the first steps on the path toward ending federal marijuana prohibition.

“We are seeing the blueprint in action and moving forward on critical legislation to protect state legal cannabis banking,” Rep. Earl Blumenauer (D-OR) told Marijuana Moment, referring to a memo he sent to House leadership last year outlining a committee-by-committee process for passing incremental cannabis bills leading up to major legislation to end federal prohibition. “Earlier this summer, the House passed protections for state and tribal cannabis laws. In the most cannabis friendly Congress in history, we need to keep up this momentum. There is still much to be done.”

There has been some disagreement within advocacy circles about whether it’s prudent to pass legislation viewed as primarily favorable to the industry before advancing comprehensive legislation that deschedules cannabis and takes steps to repair the harms of prohibition enforcement.

“It is our hope that after the successful passage of the SAFE Banking Act in the House, we will be able to advance legislation that ends the federal criminalization of cannabis once and for all,” Justin Strekal, political director of NORML, told Marijuana Moment. “Now is our time to demonstrate that marijuana law reform is both good policy and good politics.”

“We will not stop until otherwise law-abiding Americans are no longer discriminated against or criminalized due to the past or future choice to consume cannabis,” he said.

Neal Levine, CEO of the Cannabis Trade Federation, told Marijuana Moment that the group is “delighted that the U.S. House of Representatives is on the brink of passing a landmark piece of cannabis policy legislation that modernizes our antiquated banking laws to reflect the will of the people.”

“This is welcomed and long overdue news for the over 200,000 employees that work in the industry, cannabis businesses, and for public safety in the communities in which we operate,” he said. “Once the SAFE Banking Act passes the U.S. House, we call on the U.S. Senate to move quickly to protect our businesses and our workers.”

Pressure has been building all year from stakeholders and policymakers alike to get the legislation passed. Endorsements aren’t just coming from reform groups, either; 50 state banking associations, the National Association of State Treasurers, the top financial regulators of 25 states, a majority of state attorneys general and bipartisan governors of 20 states have also voiced support for the SAFE Banking Act.

Earlier this month, the head of the American Bankers Association predicted that the bill would be passed in the House “as early as September.”

GOP Senate Chair Says He Plans Marijuana Banking Vote

This story was updated to add comment from Perlmutter and Hoyer’s office.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

New ‘Marijuana 1-to-3 Act’ Would Reclassify Cannabis Under Federal Law

Published

on

Another bill to reschedule marijuana was filed in Congress on Thursday.

Rep. Greg Steube (R-FL) introduced the legislation, which is titled the “Marijuana 1-to-3 Act.” True to its name, the bill would simply require the attorney general to move cannabis from Schedule I to Schedule III under the Controlled Substances Act, with the aim of increasing research on the drug’s effects.

“As marijuana is legalized for medical and recreational use across the United States, it is important that we study the effects of the substance and the potential impacts it can have on various populations,” Steube said in a press release. “By rescheduling marijuana from a schedule I controlled substance to a schedule III controlled substance, the opportunities for research and study are drastically expanded.

“With this rescheduling, researchers can now access federal funds to research this substance and determine its medical value,” he said.

The press release came hours after a bipartisan pair of lawmakers introduced separate legislation to reschedule marijuana, also to Schedule III.

That bill contained additional provisions that would require federal agencies to develop research agendas for marijuana within one year of its enactment and also establish a system whereby universities could be designated as “Centers of Excellence in Cannabis Research” if they conducted comprehensive studies on issues related to marijuana.

Rep. Matt Gaetz (R-FL), who is a sponsor of the broader research bill, is also cosponsoring Steube’s more focused rescheduling proposal.

It’s not clear why Steube chose to file his own reclassification bill or whether the other legislation’s additional provisions were a factor.

The congressman’s two-page bill states that “the Attorney General of the United States shall, by order not later than 60 days after the date of enactment of this section, transfer marijuana…from schedule I of such Act to schedule III of such Act.”

“We hear every day about the positive health benefits of marijuana,” Steube said. “Whether it’s young children with seizure disorders, or veterans suffering from chronic pain, it is clear that there are medical benefits to marijuana and I think it’s time we remove the bureaucratic red tape that prevents us from thoroughly studying this substance.”

While he emphasized that the intent of his legislation is to encourage research into marijuana, placing cannabis in Schedule III would also have implications for marijuana businesses, who are currently ineligible for federal tax deductions under an Internal Revenue Code section that applies to anyone “trafficking in controlled substances” in Schedule I or II.

Read the full text of the bill below: 

Marijuana 1-to-3[1] by Marijuana Moment on Scribd

Former Anti-Legalization Clinton Cabinet Official Files Marijuana Reclassification Bill In Congress

Photo by Ndispensable.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

GOP Senate Chair Says He Plans Marijuana Banking Vote

Published

on

The Republican chair of the Senate Banking Committee said on Thursday that his panel will hold a vote on legislation allowing banks to service state-legal marijuana businesses this year.

Chairman Mike Crapo (R-ID) told Politico that while he doesn’t support ending federal cannabis prohibition, his committee will take up the industry’s banking issues, which was the subject of a hearing the panel held in July. Because marijuana remains federally illegal, many financial institutions remain wary of taking on cannabis business clients—forcing them to operate on a cash-only basis—and there’s a growing bipartisan call to resolve the problem.

“We’re working to try to get a bill ready,” the senator said. “I’m looking to see whether we can thread the needle.”

Legislation to provide financial services to marijuana businesses—the Secure and Fair Enforcement (SAFE) Banking Act—already exists and was approved by the House Financial Services Committee in March. That bill has 206 cosponsors, including 26 Republicans. The companion Senate bill has nearly a third of the chamber signed on.

It’s not clear what changes Crapo is hoping for, but there’s been talk of adding hemp-specific banking protections, or including language to prevent activities such as Operation Choke Point, an Obama-era policy that conservatives view as biased against certain industries such as gun manufacturers, in order to bolster the proposal’s GOP appeal.

This development comes as Congress returns from a summer recess. Cannabis reform advocates hoped that the Democratic-controlled House would put the SAFE Act to a vote before August, but that window passed.

There have been renewed rumors that House leadership is planning to schedule a vote on the SAFE Act soon, but some dispute has broken out among cannabis reform supporters about the notion of passing a bill seen as industry-focused prior to moving broader legislation to deschedule marijuana and repair the harms of past prohibition enforcement.

Many supporters of more far-reaching moves have zeroed in on a bill House Judiciary Committee Chairman Jerrold Nadler (D-NY) filed, but it’s unclear when that legislation would be able to see a markup by the panel, which for now is focused on issues such as gun reform and the prospect of impeachment proceedings.

If the Republican-controlled Senate were to pass marijuana banking legislation soon, it could increase political pressure on House majority Democrats to follow suit lest they be seen as lagging on an issue on which their party has increasingly sought to lead.

Don Murphy, federal policies director for the Marijuana Policy Project, told Marijuana Moment that polling in Crapo’s home state of Idaho—one of only three states that currently have no legal cannabis laws on the books—shows that voters in the state support cannabis reform and that “it appears Chairman Crapo is seeing similar results.”

“Apparently MPP hasn’t done the only marijuana poll in Idaho recently,” he said. “Idaho voters support marijuana policy reform and with his support of the SAFE Act the Senator is moving in their direction. What took years to develop could end up in a photo finish as each chamber attempts to beat the other to a floor vote. If true, this is a very good news.”

Idaho activists are working to place a medical cannabis measure on the state’s 2020 ballot.

While it’s not clear Crapo that endorses the SAFE Act as written or that he would use an amended version of the existing bill as the vehicle to advance the issue, he’s made several statements indicating that he’s interested in a legislative fix on cannabis banking.

“We may craft our own bill or we may work with them to craft any amended legislation,” he told Politico.

“It would be terrific for the Senate Banking Committee to hold a markup on The Safe Banking Act, which we believe would result in a favorable bipartisan vote,” NORML Political Director Justin Strekal told Marijuana Moment. “Now more than ever, members of Congress spanning all types of geographic and political diversity recognize the need to amend existing law and move us towards ending federal prohibition.”

Crapo told Politico that he’s particularly interested in passing cannabis banking reform legislation because of the negative impact of the ban on ancillary businesses like plumbing and hardware companies that work with such businesses but don’t deal directly with marijuana.

The head of the American Bankers Association (ABA) predicted last week that the House would vote on the legislation before October.

“THIS is a very important development- thank you [Sen. Crapo] for helping advance this legislation that will allow people and businesses access to the banking sector in states that have legalized cannabis and address the state/federal law inconsistency,” he wrote in response to the senator’s latest comments.

Politically, passing the banking bill in the Senate could give Sen. Cory Gardner (R-CO), its chief GOP cosponsor, a much-needed win heading toward next year’s election. Democratic candidates, including former Colorado Gov. John Hickenlooper (D) are targeting the seat, and Gardner has made much of his work to support the state’s legal cannabis market.

DEA Wants 3.2 Million Grams Of Marijuana Legally Grown In 2020

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!